Loading...
Ajanta Pharma Limited — Oseltamivir Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #10 for Oseltamivir · $300.0K export value · DGFT Verified
Ajanta Pharma Limited is the #10 Indian exporter of Oseltamivir with $300.0K in export value and 6 verified shipments. Ajanta Pharma Limited holds a 0.3% market share in Oseltamivir exports across 1 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $34.4M | 687 | 58.4% |
| CHINA | $8.0M | 159 | 13.5% |
| CANADA | $4.7M | 93 | 7.9% |
| KAZAKHSTAN | $1.9M | 40 | 3.3% |
| SOUTH AFRICA | $1.6M | 33 | 2.8% |
| BRAZIL | $1.6M | 31 | 2.6% |
| MALAYSIA | $1.3M | 373 | 2.2% |
| MALTA | $1.3M | 43 | 2.2% |
| UNITED ARAB EMIRATES | $957.9K | 197 | 1.6% |
| HONG KONG | $800.0K | 16 | 1.4% |
India exports Oseltamivir to 79 countries. The top destination is UNITED STATES (58.4%), followed by CHINA and CANADA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $4.4M | 88 |
| NATCO PHARMA (CANADA) INC | CANADA | $3.0M | 59 |
| AMNEAL PHARMACEUTICALS, LLC (KY) | UNITED STATES | $2.4M | 47 |
| STRIDES PHARMA INC | UNITED STATES | $1.6M | 33 |
| NANJING JULY PHARMACEUTICAL TECHNOL |
India exported $62.0M worth of Oseltamivir through 2,149 shipments from 118 suppliers to 79 countries, serving 314 buyers globally. Ajanta Pharma Limited contributes $300.0K to this total, accounting for 0.3% of India's Oseltamivir exports.
Ajanta Pharma Limited's average Oseltamivir shipment value is $50.0K per consignment, based on 6 shipments totaling $300.0K.
Ajanta Pharma Limited ranks #10 among 118 Indian Oseltamivir exporters with a 0.3% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($12.3M), HETERO LABS LIMITED ($12.0M), LUPIN LIMITED ($9.0M). Ajanta Pharma Limited processed 6 shipments to 1 destination countries.
What Ajanta Pharma Limited must comply with to export Oseltamivir to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | MYLAN LABORATORIES LIMITED | $400.0K | 8 | 2 | $50.0K |
| 14 | CIPLA LIMITED | $400.0K | 8 | 1 | $50.0K |
| 10 | AJANTA PHARMA LIMITED ★ | $300.0K | 6 | 1 | $50.0K |
| 15 | ALEMBIC PHARMACEUTICALS LTD | $200.0K | 4 | 1 | $50.0K |
Ajanta Pharma Limited ranks among 118 Indian Oseltamivir exporters.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 348 | 16.2% |
| CHENNAI AIR CARGO ACC (INMAA4) | 201 | 9.4% |
| HYDERABAD ACC (INHYD4) | 182 | 8.5% |
| SAHAR AIR | 151 | 7.0% |
| HYDERABAD ICD (INSNF6) | 129 | 6.0% |
| CHENNAI AIR | 125 | 5.8% |
| HYDERABAD ICD | 119 | 5.5% |
| HYDERABAD AIR | 108 | 5.0% |
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Oseltamivir, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Oseltamivir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Oseltamivir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
| CHINA |
| $1.4M |
| 27 |
| J. KNIPPER & COMPANY | UNITED STATES | $1.0M | 20 |
| CHONGQING PHARMACEUTICAL (GROUP) CO | CHINA | $700.0K | 14 |
| NATCO PHARMA CANADA INC | CANADA | $400.0K | 8 |
| MACLEODS PHARMACEUTICAL LIMITED LLC | UKRAINE | $300.0K | 6 |
| XXANTXXPHAXXA UXX INX | UNITED STATES | $150.0K | 3 |
India's Oseltamivir is purchased by 314 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by NATCO PHARMA (CANADA) INC and AMNEAL PHARMACEUTICALS, LLC (KY).
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 79+ countries, 314+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oseltamivir. For current shipment-level data, contact TransData Nexus.